Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/28714
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSantra, Lakshman-
dc.contributor.authorRajmani, R S-
dc.contributor.authorKumar, G V P P S Ravi-
dc.contributor.authorDhara, Sujoy K-
dc.contributor.authorSaxena, Shikha-
dc.contributor.authorSahoo, Aditya Prasad-
dc.contributor.authorDesai, G S-
dc.contributor.authorSingh, Lakshyaveer-
dc.contributor.authorChaturvedi, Uttara-
dc.contributor.authorKumar, Sudesh-
dc.contributor.authorTiwari, Ashok K-
dc.date.accessioned2014-05-01T10:50:26Z-
dc.date.available2014-05-01T10:50:26Z-
dc.date.issued2014-01-
dc.identifier.issn0975-0967 (Online); 0972-5849 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/28714-
dc.description41-46en_US
dc.description.abstractThe use of chemotherapy and/or radiotherapy for treatment of cancer is limited due to genotoxic side effects on healthy cells, involvement of anti-apoptotic signal transduction pathways that prevent cell death, and requirement of functional p53 for induction of apoptosis in cancerous cells. Efforts are beings made worldwide to develop new anticancer therapies as an alternative to chemotherapy. And viral gene therapy is one of the most potent therapeutics that is being ventured worldwide. Canine parvovirus-2 (CPV-2) is one of those viruses that have an inherent oncolytic property. The non-structural protein-1 (NS1 protein) of CPV-2 plays a major role in parvoviral cytotoxicity and pathogenicity in permissive cells. The oncolytic potential of CPV2-NS1 has been established in vitro. Prior to taking up the in vivo studies, the present study was undertaken to clone Canine Parvovirus NS1 gene and reporter gene GFP in eukaryotic expression vector pVIVO2-mcs, and to characterize the double construct in mammalian cells. The genes were successfully cloned in pVIVO2-mcs and characterized for their expression as demonstrated by fluorescence microscopy and immunofluorescence staining. This characterized double gene construct will further be used to evaluate the oncolytic potential of CPV-2 NS1 in experimentally induced in vivo tumour model.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJBT Vol.13(1) [January 2014]en_US
dc.subjectCanceren_US
dc.subjectCPV-2en_US
dc.subjectNS1en_US
dc.subjectViral gene oncotherapyen_US
dc.titleIn vitro cloning of canine parvovirus NS1 gene and reporter gene GFP in eukaryotic expression vector pVIVO2-mcs and characterization of the double gene construct in mammalian cellsen_US
dc.typeArticleen_US
Appears in Collections:IJBT Vol.13(1) [January 2014]

Files in This Item:
File Description SizeFormat 
IJBT 13(1) 41-46.pdf197.26 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.